This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tomoda, H. Articles by Aoki, N. Search for Related Content PubMed PubMed Citation Articles by Tomoda, H. Articles by Aoki, N. Pubmed/NCBI databases Medline Plus Health Information Angioplasty Heart Attack Social Bookmarking                         What's this?

Right Bundle Branch Block in Acute Myocardial Infarction Treated by Primary Coronary Angioplasty and Stenting

Department of Cardiology, Tokai University Hospital, Kanagawa, Japan, tomoda{at}is.icc.u-tokai.ac.jp

Naoto Aoki, MD

Department of Cardiology, Yamato Seiwa Hospital, Kanagawa, Japan

Patients with right bundle branch block (RBBB) in acute myocardial infarction (AMI) have a significantly higher mortality rate even with the advent of thrombolytic therapy. This study was undertaken to assess the impact of primary percutaneous transluminal coronary angioplasty (PTCA) and stenting on the outcome of patients with RBBB in AMI. A total of 600 patients with AMI who underwent primary PTCA and stenting (rate: 61%) <12 hours of onset were studied. A 12-lead ECG was obtained at least every 6 hours. Serial creatine kinase was measured, and left ventricular ejection fraction was obtained during the hospital stay. Among 600 patients with AMI, 94 patients (15.7%) had RBBB; it was persistent in 31 (33%) and transient in 63 (67%). In-hospital mortality rate was 7.3% in patients without RBBB, 7.9% in transient RBBB, and 25.8% in persistent RBBB (p<0.02). The incidence of heart failure was 26.5% in those without RBBB, 34.9% in transient RBBB, and 58.1% in persistent RBBB (p<0.001). There was no significant difference among these 3 groups in ventricular arrhythmias and complete atrioventricular block. Peak creatine kinase was 3,214 ±2,293 U/L in those without RBBB, 4,558 ±3,316 U/L in transient RBBB (p<0.001), and 5,635 ±3,920 U/L in persistent RBBB (p<0.001). Left ventricular ejection fraction was 50 ±11% in those without RBBB, 47 ±11% in transient RBBB (p<0.05), and 42 ±13% in persistent RBBB (p<0.001). Patients with AMI treated by primary PTCA and stenting had an increased incidence of transient RBBB, especially following reperfusion therapy, although the clinical outcome was similar to that of those without RBBB. In contrast, there was no satisfactory improvement in clinical outcomes in those with persistent RBBB.

Angiology, Vol. 56, No. 2, 131-136 (2005)
DOI: 10.1177/000331970505600202


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?